Back to Bills
SENATE-BILL 2345119th Congress

SENATE-BILL 2345: S.2345 - Short on Competition Act

Introduced: July 17, 2025
Status: Referred to Committee
supported

AI-Powered Summary

Generated by AI Analysis

SENATE-BILL 2345 aims to improve access to affordable medications by expediting the approval and importation of generic prescription drugs, particularly in situations of drug shortages or in marginally competitive markets. The bill addresses major themes such as healthcare access, safety and effectiveness of medications, and regulatory discretion. Key provisions include allowing temporary importation of drugs for up to three years, defining criteria for marginally competitive markets, and establishing annual reporting requirements on drug shortages and importations. Implementation of the bill will require the Secretary to assess drug safety and market conditions, with a focus on transparency and accountability. Potential impacts include enhanced access to necessary medications for individuals, although concerns regarding due process and regulatory discretion may arise, particularly if individuals feel their rights to access medications are unjustly restricted.

Demographic Impact Analysis

AI Demographics Analysis

Summary

Overall Constitutional Implications

The bill has significant implications for individual rights, particularly in enhancing access to essential medications for various demographic groups. By potentially lowering drug costs and increasing availability, it supports the health and welfare of individuals, especially those in vulnerable populations.

Key Individual Rights

  • Right to Health Care Access
  • Equal Protection under the Law

Constitutional Provisions

  • Due Process Clause of the Fourteenth Amendment
  • Equal Protection Clause
  • Commerce Clause

Potential Constitutional Challenges

While the bill supports individual rights, it may face challenges related to the safety and efficacy of imported drugs, which could impact health rights. Additionally, if the benefits are not equitably distributed, it could raise equal protection concerns.

Summary

SENATE-BILL 2345 seeks to improve access to affordable medications, which is crucial for individuals across various demographic categories, including low-income individuals, seniors, and those with chronic conditions. The bill's provisions align with constitutional protections by promoting public health and welfare, although careful implementation is necessary to ensure equitable access and safety.

Constitutional Analysis

supported

This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.

Analysis generated using AI-powered review of constitutional principles and legal precedents.

Take Action

Text 50409

💡 How to use:

These links will start a conversation with ResistBot. When prompted, mention S. 2345 to reference this bill.

Contact Your Representatives

Write to YOUR elected officials about this bill

Rate This Bill

Sign in to save a private rating for this bill and track your civic engagement over time.

Sign In Free

Policy Topics

Timeline

July 17, 2025

Bill Introduced

Current

Referred to Committee

June 12, 2026

Last Updated

Ask the Constitutional AI About This Bill

Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.

Sign In Free to Chat